Quantify host-assisted solubility improvement with binding constants and stoichiometry. Review scenario outputs and phase metrics. Get tables and downloads for reproducible formulation studies today.
| Scenario | Intrinsic Solubility | Host Conc. | K | n | Accessibility | Apparent Solubility |
|---|---|---|---|---|---|---|
| Screen A | 0.80 mg/mL | 12 mM | 450 M-1 | 1.0 | 85% | 4.472 mg/mL |
| Screen B | 0.50 mg/mL | 8 mM | 300 M-1 | 1.0 | 90% | 1.580 mg/mL |
| Screen C | 1.20 mg/mL | 20 mM | 150 M-1 | 1.2 | 70% | 2.273 mg/mL |
Effective host concentration: Ceff = Chost × Accessibility Factor.
Binding term: B = K × (Ceff,M)n, where Ceff,M is the effective host concentration in molar units.
Apparent solubility: Sapp = S0 × (1 + B).
Enhancement ratio: ER = Sapp / S0.
Complexed fraction: ((Sapp - S0) / Sapp) × 100.
Required volume: V = Target Dose / Sapp.
This calculator is an early-stage screening model. It estimates apparent solubility improvement from host-guest complexation and an accessibility adjustment. It does not replace measured phase-solubility studies.
Supramolecular solubility enhancement helps formulators improve the apparent solubility of poorly soluble guests. The method uses host molecules that form reversible inclusion or association complexes. These complexes keep more guest molecules dispersed in solution. Better apparent solubility can support oral, topical, and analytical applications.
A practical calculator makes screening easier. It combines intrinsic solubility, host concentration, binding strength, and stoichiometry into one estimate. This allows fast comparison between formulation scenarios. It also helps teams judge whether a planned host level is enough for a target dose and batch volume.
The core idea is simple. First, start with the guest's intrinsic solubility in the selected medium. Next, estimate the effective host concentration after applying the accessibility factor. Then use the binding constant to estimate how much extra guest can remain solubilized through complex formation. The result is an apparent solubility value rather than a pure thermodynamic constant.
This model is useful during early development. It supports cyclodextrin work, macrocycle screening, and host-guest feasibility checks. It can also guide experiments by showing how enhancement ratio changes when concentration or affinity changes. When the enhancement factor becomes large, the formulator can prioritize that host system for laboratory confirmation.
The outputs also help with dosage planning. Apparent solubility can be converted into dissolved mass at a chosen volume. Minimum required volume for a target dose can then be estimated. These two values are often more actionable than the enhancement ratio alone. They show whether the formulation can realistically carry the intended amount of guest.
Results still need experimental verification. Real systems may deviate because of pH, ionic strength, co-solvents, self-association, competing equilibria, or precipitation kinetics. Stoichiometry can also change with concentration. For that reason, the calculator should be treated as a decision support tool. It narrows the search space, saves bench time, and improves screening discipline. Measured phase-solubility studies remain the final reference for formulation selection and scale-up decisions.
Use this page to compare host loadings before experiments begin. Small input changes can reveal nonlinear gains, weak candidates, or unnecessary excipient excess. That makes preformulation discussions more evidence based, improves documentation, and supports clearer optimization priorities across teams and batches during early screening.
It estimates apparent solubility improvement caused by supramolecular host-guest complexation. It also reports enhancement ratio, complexed fraction, dissolved mass, and the estimated volume needed for a target payload.
Intrinsic solubility is the baseline without host assistance. Every improvement metric starts from that number, so inaccurate baseline data will distort the enhancement ratio and all mass-based outputs.
It represents the usable fraction of host concentration in the real system. Losses from aggregation, incomplete mixing, competing species, or process limits can reduce effective host availability.
Yes. It can support early cyclodextrin screening if you have a working binding constant estimate and a reasonable assumption for accessible host concentration.
It changes how strongly host concentration affects the binding term. A value near one reflects simple proportional behavior, while larger values create steeper concentration sensitivity.
No. It is a model-based estimate for screening and planning. Laboratory phase-solubility experiments are still needed to confirm the real formulation behavior.
It tells you whether the current apparent solubility and batch volume can support the target payload plus the selected design margin. That helps with quick feasibility checks.
Export when comparing candidates, documenting assumptions, or sharing preformulation scenarios. The files make internal review easier and preserve the calculated outputs with the chosen inputs.
Important Note: All the Calculators listed in this site are for educational purpose only and we do not guarentee the accuracy of results. Please do consult with other sources as well.